Damora Therapeutics, Inc. GLTO
Set alert
21.58 USD 0.00 0.00%
As of Jun 4, 12:02 PM ET
21.58 Day range 23.54
4.40 52-week range 23.50
- YTD
- -6.21%
- 1 year
- +659.86%
- Open
- 22.26
- Prev close
- 21.58
- Mkt cap
- 6.22M
- Vol
- 609
- Avg vol
- 26.14K
- EPS
- -19.11
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 21.58
- High
- 23.54
- Forward P/E
- -0.25
- Beta
- 1.25
- Short ratio
- 1.08
- Inst. own
- 12.03%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 6.25
- 200-d avg
- 12.56
- 1y target
- 10.00
Financial health
Altman Z-Score
-1.14 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.2×
FY 2018 5y median -0.5× FY 2025
P/S 0.0×
FY 2018 5y median 0.0× FY 2025
P/B 0.1×
FY 2018 5y median 0.5× FY 2025
P/FCF -4.7×
FY 2018 5y median -0.7× FY 2025
EV/EBITDA 1.1×
FY 2018 5y median 0.1× FY 2025
EV/Sales 0.0×
FY 2018 5y median 0.0× FY 2025
FCF Yield -21.3%
FY 2018 5y median -147.6% FY 2025
Profitability
Gross Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2018 5y median 0.0% FY 2025
ROE -87.3%
FY 2018 5y median -99.8% FY 2025
ROIC -87.7%
FY 2018 5y median -97.8% FY 2025
ROA -80.5%
FY 2018 5y median -84.2% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2018 FY 2025
Operating Income -847.3%
FY 2018 FY 2025
EPS (diluted) -725.6%
FY 2018 FY 2025
Free Cash Flow 63.9%
FY 2018 FY 2025
Financial Health
Current Ratio 13.0×
FY 2018 5y median 13.0× FY 2025
Quick Ratio 13.0×
FY 2018 5y median 13.0× FY 2025
Debt / Equity 0.0×
FY 2018 5y median 0.0× FY 2025
Net Debt / EBITDA 1.2×
FY 2018 5y median 0.7× FY 2025
Interest Coverage 0.0×
FY 2018 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31